Limba
Romanian
Romanian
English|
Vulinacimab (Anti-VEGFR2 / KDR / CD309), 1mg*25
33.397,21 RON
SKU
SKM_A3110_1mg*25
Vulinacimab (Anti-VEGFR2 / KDR / CD309) is a monoclonal antibody targeting VEGFR-2. It has potential anti-angiogenesis and antineoplastic activities and can be used in the research of cancers. MW :145.38 KD.
| Price | 27.601,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Vulinacimab (Anti-VEGFR2 / KDR / CD309) is a monoclonal antibody targeting VEGFR-2. It has potential anti-angiogenesis and antineoplastic activities and can be used in the research of cancers. MW :145.38 KD. |
